{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:43:44Z","timestamp":1792514624596,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T00:00:00Z","timestamp":1553472000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003669","name":"Korea Centers for Disease Control & Prevention","doi-asserted-by":"publisher","award":["2011E3300300, 2012E3301100, 2013E3301600, 2013E3301601, 2013E3301602, and 2016E3300200"],"award-info":[{"award-number":["2011E3300300, 2012E3301100, 2013E3301600, 2013E3301601, 2013E3301602, and 2016E3300200"]}],"id":[{"id":"10.13039\/501100003669","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12882-019-1292-3","type":"journal-article","created":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T09:02:41Z","timestamp":1553504561000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Urinary angiotensinogen level is associated with potassium homeostasis and clinical outcome in patients with polycystic kidney disease: a prospective cohort study"],"prefix":"10.1186","volume":"20","author":[{"name":"Representing the KNOW-CKD Investigators Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyoungnae","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seohyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Hyun","family":"Jhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae-Ryong","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Tak","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hyeok","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joongyub","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Wan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeong Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Kyu","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-Wook","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu Hun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9183-4507","authenticated-orcid":false,"given":"Tae-Hyun","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,25]]},"reference":[{"key":"1292_CR1","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1681\/ASN.2013111184","volume":"25","author":"RW Schrier","year":"2014","unstructured":"Schrier RW, Brosnahan G, Cadnapaphornchai MA, Chonchol M, Friend K, Gitomer B, et al. Predictors of autosomal dominant polycystic kidney disease progression. J Am Soc Nephrol. 2014;25:2399\u2013418.","journal-title":"J Am Soc Nephrol"},{"key":"1292_CR2","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1681\/ASN.V121194","volume":"12","author":"T Ecder","year":"2001","unstructured":"Ecder T, Schrier RW. Hypertension in autosomal-dominant polycystic kidney disease: early occurrence and unique aspects. J Am Soc Nephrol. 2001;12:194\u2013200.","journal-title":"J Am Soc Nephrol"},{"key":"1292_CR3","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/ki.1990.330","volume":"38","author":"PA Gabow","year":"1990","unstructured":"Gabow PA, Chapman AB, Johnson AM, Tangel DJ, Duley IT, Kaehny WD, et al. Renal structure and hypertension in autosomal dominant polycystic kidney disease. Kidney Int. 1990;38:1177\u201380.","journal-title":"Kidney Int"},{"key":"1292_CR4","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/ki.1992.195","volume":"41","author":"PA Gabow","year":"1992","unstructured":"Gabow PA, Johnson AM, Kaehny WD, Kimberling WJ, Lezotte DC, Duley IT, et al. Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int. 1992;41:1311\u20139.","journal-title":"Kidney Int"},{"key":"1292_CR5","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1093\/ndt\/gfr467","volume":"27","author":"B Orskov","year":"2012","unstructured":"Orskov B, Sorensen VR, Feldt-Rasmussen B, Strandgaard S. Changes in causes of death and risk of cancer in Danish patients with autosomal dominant polycystic kidney disease and end-stage renal disease. Nephrol Dial Transplant. 2012;27:1607\u201313.","journal-title":"Nephrol Dial Transplant"},{"key":"1292_CR6","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1056\/NEJM199010183231602","volume":"323","author":"AB Chapman","year":"1990","unstructured":"Chapman AB, Johnson A, Gabow PA, Schrier RW. The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. N Engl J Med. 1990;323:1091\u20136.","journal-title":"N Engl J Med"},{"key":"1292_CR7","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/S0025-6196(12)61724-8","volume":"66","author":"VE Torres","year":"1991","unstructured":"Torres VE, Wilson DM, Burnett JC Jr, Johnson CM, Offord KP. Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease. Mayo Clin Proc. 1991;66:1010\u20137.","journal-title":"Mayo Clin Proc"},{"key":"1292_CR8","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1001\/jama.285.21.2719","volume":"285","author":"LY Agodoa","year":"2001","unstructured":"Agodoa LY, Appel L, Bakris GL, Beck G, Bourgoignie J, Briggs JP, et al. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA. 2001;285:2719\u201328.","journal-title":"JAMA"},{"key":"1292_CR9","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1056\/NEJM199604113341502","volume":"334","author":"G Maschio","year":"1996","unstructured":"Maschio G, Alberti D, Janin G, Locatelli F, Mann JF, Motolese M, et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The angiotensin-converting-enzyme inhibition in progressive renal insufficiency study group. N Engl J Med. 1996;334:939\u201345.","journal-title":"N Engl J Med"},{"key":"1292_CR10","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1056\/NEJMoa011161","volume":"345","author":"BM Brenner","year":"2001","unstructured":"Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345:861\u20139.","journal-title":"N Engl J Med"},{"key":"1292_CR11","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1056\/NEJMoa011303","volume":"345","author":"EJ Lewis","year":"2001","unstructured":"Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345:851\u201360.","journal-title":"N Engl J Med"},{"key":"1292_CR12","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S0140-6736(08)61236-2","volume":"372","author":"JF Mann","year":"2008","unstructured":"Mann JF, Schmieder RE, McQueen M, Dyal L, Schumacher H, Pogue J, et al. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet. 2008;372:547\u201353.","journal-title":"Lancet"},{"key":"1292_CR13","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1056\/NEJMoa1303154","volume":"369","author":"LF Fried","year":"2013","unstructured":"Fried LF, Emanuele N, Zhang JH, Brophy M, Conner TA, Duckworth W, et al. Combined angiotensin inhibition for the treatment of diabetic nephropathy. N Engl J Med. 2013;369:1892\u2013903.","journal-title":"N Engl J Med"},{"key":"1292_CR14","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1056\/NEJMoa1208799","volume":"367","author":"HH Parving","year":"2012","unstructured":"Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, et al. Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med. 2012;367:2204\u201313.","journal-title":"N Engl J Med"},{"key":"1292_CR15","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1056\/NEJMoa1402686","volume":"371","author":"VE Torres","year":"2014","unstructured":"Torres VE, Abebe KZ, Chapman AB, Schrier RW, Braun WE, Steinman TI, et al. Angiotensin blockade in late autosomal dominant polycystic kidney disease. N Engl J Med. 2014;371:2267\u201376.","journal-title":"N Engl J Med"},{"key":"1292_CR16","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMoa1402685","volume":"371","author":"RW Schrier","year":"2014","unstructured":"Schrier RW, Abebe KZ, Perrone RD, Torres VE, Braun WE, Steinman TI, et al. Blood pressure in early autosomal dominant polycystic kidney disease. N Engl J Med. 2014;371:2255\u201366.","journal-title":"N Engl J Med"},{"key":"1292_CR17","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1146\/annurev.physiol.010908.163241","volume":"71","author":"JH Youn","year":"2009","unstructured":"Youn JH, McDonough AA. Recent advances in understanding integrative control of potassium homeostasis. Annu Rev Physiol. 2009;71:381\u2013401.","journal-title":"Annu Rev Physiol"},{"key":"1292_CR18","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1681\/ASN.2006060554","volume":"18","author":"T Yamamoto","year":"2007","unstructured":"Yamamoto T, Nakagawa T, Suzuki H, Ohashi N, Fukasawa H, Fujigaki Y, et al. Urinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney disease. J Am Soc Nephrol. 2007;18:1558\u201365.","journal-title":"J Am Soc Nephrol"},{"key":"1292_CR19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1471-2369-15-80","volume":"15","author":"KH Oh","year":"2014","unstructured":"Oh KH, Park SK, Park HC, Chin HJ, Chae DW, Choi KH, et al. KNOW-CKD (KoreaN cohort study for outcome in patients with chronic kidney disease): design and methods. BMC Nephrol. 2014;15:80.","journal-title":"BMC Nephrol"},{"key":"1292_CR20","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1681\/ASN.2007091017","volume":"19","author":"MJ Choi","year":"2008","unstructured":"Choi MJ, Ziyadeh FN. The utility of the transtubular potassium gradient in the evaluation of hyperkalemia. J Am Soc Nephrol. 2008;19:424\u20136.","journal-title":"J Am Soc Nephrol"},{"key":"1292_CR21","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604\u201312.","journal-title":"Ann Intern Med"},{"key":"1292_CR22","first-page":"226","volume":"12","author":"ML West","year":"1986","unstructured":"West ML, Bendz O, Chen CB, Singer GG, Richardson RM, Sonnenberg H, et al. Development of a test to evaluate the transtubular potassium concentration gradient in the cortical collecting duct in vivo. Miner Electrolyte Metab. 1986;12:226\u201333.","journal-title":"Miner Electrolyte Metab"},{"key":"1292_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1161\/01.HYP.0000050102.90932.CF","volume":"41","author":"H Kobori","year":"2003","unstructured":"Kobori H, Nishiyama A, Harrison-Bernard LM, Navar LG. Urinary angiotensinogen as an indicator of intrarenal angiotensin status in hypertension. Hypertension. 2003;41:42\u20139.","journal-title":"Hypertension"},{"key":"1292_CR24","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1046\/j.1523-1755.2002.00155.x","volume":"61","author":"H Kobori","year":"2002","unstructured":"Kobori H, Harrison-Bernard LM, Navar LG. Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production. Kidney Int. 2002;61:579\u201385.","journal-title":"Kidney Int"},{"key":"1292_CR25","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12882-015-0075-8","volume":"16","author":"HC Park","year":"2015","unstructured":"Park HC, Kang AY, Jang JY, Kim H, Han M, Oh KH, et al. Increased urinary angiotensinogen\/creatinine (AGT\/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients. BMC Nephrol. 2015;16:86.","journal-title":"BMC Nephrol"},{"key":"1292_CR26","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1159\/000354317","volume":"38","author":"I Kocyigit","year":"2013","unstructured":"Kocyigit I, Yilmaz MI, Unal A, Ozturk F, Eroglu E, Yazici C, et al. A link between the intrarenal renin angiotensin system and hypertension in autosomal dominant polycystic kidney disease. Am J Nephrol. 2013;38:218\u201325.","journal-title":"Am J Nephrol"},{"key":"1292_CR27","doi-asserted-by":"publisher","first-page":"F874","DOI":"10.1152\/ajprenal.00209.2017","volume":"313","author":"M Salih","year":"2017","unstructured":"Salih M, Bovee DM, Roksnoer LCW, Casteleijn NF, Bakker SJL, Gansevoort RT, et al. Urinary renin-angiotensin markers in polycystic kidney disease. Am J Physiol Renal Physiol. 2017;313:F874\u2013F81.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1292_CR28","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/ki.1992.297","volume":"42","author":"VE Torres","year":"1992","unstructured":"Torres VE, Donovan KA, Scicli G, Holley KE, Thibodeau SN, Carretero OA, et al. Synthesis of renin by tubulocystic epithelium in autosomal-dominant polycystic kidney disease. Kidney Int. 1992;42:364\u201373.","journal-title":"Kidney Int"},{"key":"1292_CR29","doi-asserted-by":"publisher","first-page":"F775","DOI":"10.1152\/ajprenal.00370.2003","volume":"287","author":"M Loghman-Adham","year":"2004","unstructured":"Loghman-Adham M, Soto CE, Inagami T, Cassis L. The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease. Am J Physiol Renal Physiol. 2004;287:F775\u201388.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1292_CR30","doi-asserted-by":"publisher","first-page":"41935","DOI":"10.1074\/jbc.M110.150284","volume":"285","author":"M Pohl","year":"2010","unstructured":"Pohl M, Kaminski H, Castrop H, Bader M, Himmerkus N, Bleich M, et al. Intrarenal renin angiotensin system revisited: role of megalin-dependent endocytosis along the proximal nephron. J Biol Chem. 2010;285:41935\u201346.","journal-title":"J Biol Chem"},{"key":"1292_CR31","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1161\/HYPERTENSIONAHA.115.07012","volume":"67","author":"LC Roksnoer","year":"2016","unstructured":"Roksnoer LC, Heijnen BF, Nakano D, Peti-Peterdi J, Walsh SB, Garrelds IM, et al. On the origin of urinary renin: a translational approach. Hypertension. 2016;67:927\u201333.","journal-title":"Hypertension"},{"key":"1292_CR32","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1124\/pr.59.3.3","volume":"59","author":"H Kobori","year":"2007","unstructured":"Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev. 2007;59:251\u201387.","journal-title":"Pharmacol Rev"},{"key":"1292_CR33","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1097\/01.ASN.0000131528.00773.A9","volume":"15","author":"ML Graciano","year":"2004","unstructured":"Graciano ML, Cavaglieri Rde C, Delle H, Dominguez WV, Casarini DE, Malheiros DM, et al. Intrarenal renin-angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis. J Am Soc Nephrol. 2004;15:1805\u201315.","journal-title":"J Am Soc Nephrol"},{"key":"1292_CR34","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1046\/j.1523-1755.2003.00065.x","volume":"64","author":"D Prete Del","year":"2003","unstructured":"Del Prete D, Gambaro G, Lupo A, Anglani F, Brezzi B, Magistroni R, et al. Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis. Kidney Int. 2003;64:149\u201359.","journal-title":"Kidney Int"},{"key":"1292_CR35","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1093\/ndt\/gfs011","volume":"27","author":"KT Mills","year":"2012","unstructured":"Mills KT, Kobori H, Hamm LL, Alper AB, Khan IE, Rahman M, et al. Increased urinary excretion of angiotensinogen is associated with risk of chronic kidney disease. Nephrol Dial Transplant. 2012;27:3176\u201381.","journal-title":"Nephrol Dial Transplant"},{"key":"1292_CR36","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000168062","volume":"10","author":"KS Kamel","year":"1990","unstructured":"Kamel KS, Ethier JH, Richardson RM, Bear RA, Halperin ML. Urine electrolytes and osmolality: when and how to use them. Am J Nephrol. 1990;10:89\u2013102.","journal-title":"Am J Nephrol"},{"key":"1292_CR37","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004175","volume":"95","author":"S Lai","year":"2016","unstructured":"Lai S, Petramala L, Mastroluca D, Petraglia E, Di Gaeta A, Indino E, et al. Hyperaldosteronism and cardiovascular risk in patients with autosomal dominant polycystic kidney disease. Medicine (Baltimore). 2016;95:e4175.","journal-title":"Medicine (Baltimore)"},{"key":"1292_CR38","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1056\/NEJMc081065","volume":"359","author":"N Buchner","year":"2008","unstructured":"Buchner N, Banas B, Kramer BK. Telmisartan, ramipril, or both in patients at high risk of vascular events. N Engl J Med. 2008;359:426.","journal-title":"N Engl J Med"},{"key":"1292_CR39","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC\/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021\u2013104.","journal-title":"Eur Heart J"},{"key":"1292_CR40","first-page":"e426","volume":"138","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and Management of High Blood Pressure in adults: executive summary: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines. Circulation. 2018;138:e426\u2013e83.","journal-title":"Circulation"},{"key":"1292_CR41","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/hr.2013.80","volume":"37","author":"K Shimamoto","year":"2014","unstructured":"Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res. 2014;37:253\u2013390.","journal-title":"Hypertens Res"},{"key":"1292_CR42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S1470-2045(10)70260-6","volume":"12","author":"S Bangalore","year":"2011","unstructured":"Bangalore S, Kumar S, Kjeldsen SE, Makani H, Grossman E, Wetterslev J, et al. Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials. Lancet Oncol. 2011;12:65\u201382.","journal-title":"Lancet Oncol"},{"key":"1292_CR43","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3109\/07853890.2011.558518","volume":"44","author":"HR Jang","year":"2012","unstructured":"Jang HR, Kim SM, Lee YJ, Lee JE, Huh W, Kim DJ, et al. The origin and the clinical significance of urinary angiotensinogen in proteinuric IgA nephropathy patients. Ann Med. 2012;44:448\u201357.","journal-title":"Ann Med"},{"key":"1292_CR44","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1681\/ASN.2015010022","volume":"27","author":"J He","year":"2016","unstructured":"He J, Mills KT, Appel LJ, Yang W, Chen J, Lee BT, et al. Urinary sodium and potassium excretion and CKD progression. J Am Soc Nephrol. 2016;27:1202\u201312.","journal-title":"J Am Soc Nephrol"},{"key":"1292_CR45","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1053\/ajkd.1998.v31.pm9428447","volume":"31","author":"IW Gallen","year":"1998","unstructured":"Gallen IW, Rosa RM, Esparaz DY, Young JB, Robertson GL, Batlle D, et al. On the mechanism of the effects of potassium restriction on blood pressure and renal sodium retention. Am J Kidney Dis. 1998;31:19\u201327.","journal-title":"Am J Kidney Dis"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1292-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-019-1292-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1292-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T05:17:14Z","timestamp":1663132634000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-019-1292-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,25]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1292"],"URL":"https:\/\/doi.org\/10.1186\/s12882-019-1292-3","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,25]]},"assertion":[{"value":"12 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was carried out in accordance with the Declaration of Helsinki, and the study protocol was approved by the respective institutional review board of the participating centers, including Seoul National University Hospital, Yonsei University Severance Hospital, Kangbuk Samsung Medical Center, Seoul St. Mary\u2019s Hospital, Gil Hospital, Eulji General Hospital, Chonnam National University Hospital, and Busan Paik Hospital. All participants of the KNOW-CKD study provided informed consent voluntarily at the time of enrollment.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"104"}}